Rockwell Medical, Inc. (RMTI): Price and Financial Metrics


Rockwell Medical, Inc. (RMTI): $1.40

0.02 (+1.45%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

RMTI Stock Summary

  • With a market capitalization of $15,471,455, ROCKWELL MEDICAL INC has a greater market value than just 6.5% of US stocks.
  • The capital turnover (annual revenue relative to shareholder's equity) for RMTI is 4.27 -- better than 88.87% of US stocks.
  • With a price/sales ratio of 0.22, ROCKWELL MEDICAL INC has a higher such ratio than only 7.49% of stocks in our set.
  • If you're looking for stocks that are quantitatively similar to ROCKWELL MEDICAL INC, a group of peers worth examining would be BC, BODY, EFOI, OB, and SHYF.
  • RMTI's SEC filings can be seen here. And to visit ROCKWELL MEDICAL INC's official web site, go to www.rockwellmed.com.

RMTI Valuation Summary

  • In comparison to the median Healthcare stock, RMTI's EV/EBIT ratio is 116.79% lower, now standing at -1.1.
  • RMTI's price/sales ratio has moved down 0.8 over the prior 243 months.

Below are key valuation metrics over time for RMTI.

Stock Date P/S P/B P/E EV/EBIT
RMTI 2023-03-17 0.2 1.0 -0.6 -1.1
RMTI 2023-03-16 0.2 1.0 -0.6 -1.1
RMTI 2023-03-15 0.2 0.9 -0.6 -1.0
RMTI 2023-03-14 0.2 1.0 -0.6 -1.1
RMTI 2023-03-13 0.2 1.0 -0.6 -1.1
RMTI 2023-03-10 0.2 1.0 -0.7 -1.1

RMTI Growth Metrics

    Its 4 year price growth rate is now at -67.86%.
  • Its 2 year net cashflow from operations growth rate is now at -8.75%.
  • Its 4 year net income to common stockholders growth rate is now at -69.53%.
Over the past 49 months, RMTI's revenue has gone up $7,456,626.

The table below shows RMTI's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 68.829 -25.846 -25.26
2022-06-30 66.126 -31.819 -28.651
2022-03-31 62.581 -30.851 -32.084
2021-12-31 61.931 -33.534 -32.674
2021-09-30 61.762 -33.077 -32.396
2021-06-30 61.054 -30.91971 -32.165

RMTI's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • RMTI has a Quality Grade of D, ranking ahead of 9.74% of graded US stocks.
  • RMTI's asset turnover comes in at 0.825 -- ranking 30th of 681 Pharmaceutical Products stocks.
  • IMGN, PTE, and BCDA are the stocks whose asset turnover ratios are most correlated with RMTI.

The table below shows RMTI's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.825 0.014 -0.801
2021-03-31 0.850 0.033 -0.675
2020-12-31 0.863 0.044 -0.730
2020-09-30 0.981 0.055 -0.790
2020-06-30 1.151 0.049 -0.908
2020-03-31 1.139 0.048 -1.191

RMTI Price Target

For more insight on analysts targets of RMTI, see our RMTI price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $5.00 Average Broker Recommendation 1.5 (Moderate Buy)

RMTI Stock Price Chart Interactive Chart >

Price chart for RMTI

RMTI Price/Volume Stats

Current price $1.40 52-week high $5.50
Prev. close $1.38 52-week low $0.84
Day low $1.36 Volume 120,500
Day high $1.45 Avg. volume 328,181
50-day MA $1.80 Dividend yield N/A
200-day MA $1.43 Market Cap 13.17M

Rockwell Medical, Inc. (RMTI) Company Bio


Rockwell Medical is a biopharmaceutical company targeting end-stage renal disease and chronic kidney disease with products and services for the treatment of iron replacement, secondary hyperparathyroidism and hemodialysis. The company was founded in 1995 and is based in Wixom, Michigan.


RMTI Latest News Stream


Event/Time News Detail
Loading, please wait...

RMTI Latest Social Stream


Loading social stream, please wait...

View Full RMTI Social Stream

Latest RMTI News From Around the Web

Below are the latest news stories about ROCKWELL MEDICAL INC that investors may wish to consider to help them evaluate RMTI as an investment opportunity.

Rockwell Medical Named 'Great Place to Work'

WIXOM, Mich., February 28, 2023--Rockwell Medical has been certified as a Great Place to Work in 2023, the Company's inaugural year participating in the accreditation.

Yahoo | February 28, 2023

Rockwell Medical to Release Fourth Quarter and Full-Year 2022 Financial Results on Thursday, March 30, 2023

WIXOM, Mich., February 16, 2023--Rockwell Medical to Release Fourth Quarter and Full-Year 2022 Financial Results on Thursday, March 30, 2023.

Yahoo | February 16, 2023

Beat the Market Like Zacks: NVIDIA, Boeing, Rockwell Medical in Focus

Our time-tested methodologies were at work to help investors navigate the market well last week. Here are some of our key performance data from the past three months.

Yahoo | February 13, 2023

Rockwell Medical and Concerto Renal Services Establish New Three-Year, Multi-Million Dollar Product Purchase Agreement

WIXOM, Mich., February 13, 2023--Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a commercial healthcare company focused on providing life-sustaining products for patients suffering from blood disorders and diseases associated with the kidney, announced that the Company signed a three-year product purchase agreement with Concerto Renal Services ("Concerto"), the largest provider of dialysis in skilled nursing facilities in the United States. Under the terms of the agreement, Rockwell Medi

Yahoo | February 13, 2023

Rockwell Medical Signs Three-Year, Multi-Million Dollar Supply Agreement with Largest Non-Profit Dialysis Provider in the United States

WIXOM, Mich., February 02, 2023--Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a commercial healthcare company focused on providing life-sustaining products for patients suffering from blood disorders and diseases associated with the kidney, announced that the Company signed a three-year, multi-million dollar per annum product purchase agreement with the largest non-profit dialysis provider in the United States. As part of the agreement, Rockwell Medical will be the preferred supplier o

Yahoo | February 2, 2023

Read More 'RMTI' Stories Here

RMTI Price Returns

1-mo -37.50%
3-mo 44.33%
6-mo 10.24%
1-year -66.42%
3-year -94.81%
5-year -97.59%
YTD 37.93%
2022 -77.49%
2021 -59.41%
2020 -58.61%
2019 7.96%
2018 -61.17%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.832 seconds.